https://doi.org/10.4081/itjm.2025.1908
The role of genetic variations in metabolic syndrome: insights into etiology, diagnosis, and management
Submitted: 10 January 2025
Accepted: 17 February 2025
Published: 24 March 2025
Accepted: 17 February 2025
Abstract Views: 474
PDF: 145
HTML: 10
HTML: 10
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Authors
Metabolic syndrome (MetS) is a cluster of interrelated conditions primarily driven by excessive caloric intake, physical inactivity, and excess abdominal fat. Core features include abdominal obesity, insulin resistance, dyslipidemia, and elevated blood pressure. MetS is also closely associated with several comorbidities, such as a prothrombotic state, systemic inflammation, non-alcoholic fatty liver disease, and reproductive abnormalities. Its global prevalence is rising rapidly, particularly in urbanized areas and developing nations, reflecting changing lifestyles and dietary patterns. This surge has significant public health implications, as individuals with MetS face a twofold higher risk of developing cardiovascular diseases and a fivefold increased likelihood of progressing to type 2 diabetes. Managing MetS requires a multifaceted approach, with lifestyle modification as the cornerstone. Sustainable weight loss, achieved through dietary changes, regular physical activity, and behavioral interventions, is essential. Concurrently, it is critical to address other cardiovascular risk factors aggressively, including hypertension, hyperlipidemia, and hyperglycemia, to mitigate long-term health complications. As the prevalence of MetS continues to grow, understanding its pathophysiology and implementing comprehensive management strategies are paramount to reducing its global burden and improving patient outcomes.
Chu SS, Nguyen HA, Zhang J, et al. Towards multiplexed and multimodal biosensor platforms in real-time monitoring of metabolic disorders. Sensors 2022;22:5200.
DOI: https://doi.org/10.3390/s22145200
Alberti KGMM, Eckel RH, Grundy SM, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009;120:1640-5.
DOI: https://doi.org/10.1161/CIRCULATIONAHA.109.192644
Khunti K, Davies M. Metabolic syndrome. BMJ 2005;331:1153-4.
DOI: https://doi.org/10.1136/bmj.331.7526.1153
Girman CJ, Rhodes T, Mercuri M, et al. The metabolic syndrome and risk of major coronary events in the Scandinavian Simvastatin Survival Study (4S) and the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS). Am J Cardiol 2004;93:136-41.
DOI: https://doi.org/10.1016/j.amjcard.2003.09.028
Yki-Järvinen H. Non-alcoholic fatty liver disease as a cause and a consequence of metabolic syndrome. Lancet Diabetes Endocrinol 2014;2:901-10.
DOI: https://doi.org/10.1016/S2213-8587(14)70032-4
Tahmi M, Palta P, Luchsinger JA. Metabolic syndrome and cognitive function. Curr Cardiol Rep 2021;23:180.
DOI: https://doi.org/10.1007/s11886-021-01615-y
Belladelli F, Montorsi F, Martini A. Metabolic syndrome, obesity and cancer risk. Curr Opin Urol 2022;32:594-7.
DOI: https://doi.org/10.1097/MOU.0000000000001041
Cornier MA, Dabelea D, Hernandez TL, et al. The metabolic syndrome. Endocr Rev 2008;29:777-822.
DOI: https://doi.org/10.1210/er.2008-0024
Barati E, Ghazizadeh H, Sadabadi F, et al. Association of the IL6 gene polymorphism with component features of metabolic syndrome in obese subjects. Biochem Genet 2019;57:695-708.
DOI: https://doi.org/10.1007/s10528-019-09913-5
Chernyak YI, Kudaeva IV. Analysis of HSPA1B (+1267A>G) genetic polymorphism in patients with vibration disease in combination with metabolic syndrome. Bull Exp Biol Med 2021;171:375-8.
DOI: https://doi.org/10.1007/s10517-021-05231-2
Aghajani R, Saeidi M, Amiriani T, et al. Genetic polymorphisms -137 (G > C) (rs187238) and -607 (C > A) (rs1946518) and serum level of interleukin 18 in Fars ethnic groups with metabolic syndrome in Northern Iran. Arch Physiol Biochem 2022;128:1596-602.
DOI: https://doi.org/10.1080/13813455.2020.1784954
Sidabutar LMGB, Pongcharoen T, Suttisansanee U, et al. The association of cholesterol transport ABCG1 polymorphism towards the susceptibility of metabolic syndrome risk factor in thai adolescents. Curr Res Nutr Food Sci J 2022;10:512-20.
DOI: https://doi.org/10.12944/CRNFSJ.10.2.8
Ghareeb D, Abdelazem AS, Hussein EM, Al-Karamany AS. Association of TNF-α-308 G>A (rs1800629) polymorphism with susceptibility of metabolic syndrome. J Diabetes Metab Disord 2021;20:209-15.
DOI: https://doi.org/10.1007/s40200-021-00732-3
dos S. Araújo EP, da C. Lima SVC, Galdino OA, et al. Association of CYP2R1 and VDR polymorphisms with metabolic syndrome components in non-diabetic Brazilian adolescents. Nutrients 2022;14:4612.
DOI: https://doi.org/10.3390/nu14214612
Paderina DZ, Boiko AS, Pozhidaev IV, et al. The gender-specific association of DRD2 polymorphism with metabolic syndrome in patients with schizophrenia. Genes 2022;13:1312.
DOI: https://doi.org/10.3390/genes13081312
Barus JFA, Sudharta H, Widyadharma IPE, Ali S. VEGF gene polymorphisms in diabetic peripheral neuropathy: a systematic review and meta-analysis. Gene Expr 2024;23: 69-81.
DOI: https://doi.org/10.14218/GE.2023.00062
Yang L, Chen J, Liu D, et al. Association between SREBF2 gene polymorphisms and metabolic syndrome in clozapine-treated patients with schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 2015;56:136-41.
DOI: https://doi.org/10.1016/j.pnpbp.2014.08.015
Tabur S, Oztuzcu S, Duzen IV, et al. Role of the transient receptor potential (TRP) channel gene expressions and TRP melastatin (TRPM) channel gene polymorphisms in obesity-related metabolic syndrome. Eur Rev Med Pharmacol Sci 2015;19:1388-97.
DOI: https://doi.org/10.1530/endoabs.37.EP609
Al-Attar SA, Pollex RL, Ban MR, et al. Association between the FTO rs9939609 polymorphism and the metabolic syndrome in a non-Caucasian multi-ethnic sample. Cardiovasc Diabetol 2008;7:5.
DOI: https://doi.org/10.1186/1475-2840-7-5
Khella MS, Hamdy NM, Amin AI, El-Mesallamy HO. The (FTO) gene polymorphism is associated with metabolic syndrome risk in Egyptian females: a case-control study. BMC Med Gen 2017;18:101.
DOI: https://doi.org/10.1186/s12881-017-0461-0
Ko EJ, Kim EJ, Cho HJ, et al.Prognostic significance of three endothelial nitric oxide synthase (eNOS) polymorphisms and metabolic syndrome (MetS) in patients with colorectal cancer. Genes Genomic 2022;44:659-70.
DOI: https://doi.org/10.1007/s13258-022-01246-9
Al-Hamodi ZH, Saif-Ali R, Ismail S, et al. Plasminogen activator inhibitor-1 4G/5G polymorphism is associated with metabolic syndrome parameters in Malaysian subjects. J Clin Biochem Nutr 2012;50:184-9.
DOI: https://doi.org/10.3164/jcbn.11-48
Zenoaga-Barbăroșie C, Berc L, Vassu-Dimov T, et al.The predisposition for type 2 diabetes mellitus and metabolic syndrome, Balkan J Med Genet 2023;26:21-6.
DOI: https://doi.org/10.2478/bjmg-2023-0003
Zahary MN, Harun NS, Ridzwan N, et al. Increased risk of metabolic syndrome with genetic polymorphism of ADIPOQ among a Temiar population in Malaysia. Meta Gene 2020;24:100653.
DOI: https://doi.org/10.1016/j.mgene.2020.100653
Afrand M, Bashardoost N, Sheikhha MH, Afkhami-Ardekani M. Association between glutathione S-transferase GSTM1-T1 and P1 polymorphisms with metabolic syndrome in Zoroastrians in Yazd, Iran. Iran J Public Health 2015;44:673-82.
Kochetova OV, Viktorova TV, Mustafina OE, et al. Genetic Association of ADRA2A and ADRB3 Genes with Metabolic Syndrome among the Tatars. Genetika 2015;51:830-4.
DOI: https://doi.org/10.1134/S1022795415070066
Deram S, Nicolau CY, Perez-Martinez P, et al. Effects of perilipin (PLIN) gene variation on metabolic syndrome risk and weight loss in obese children and adolescents. J Clin Endocrinol Metab 2008;93:4933-40.
DOI: https://doi.org/10.1210/jc.2008-0947
Huang X, Ye Q, Zhang Y, et al. Fine-mapping of the PLCL2 gene identifies candidate variants associated with ischaemic stroke risk in metabolic syndrome patients. Front Neurol 2022;12:743169.
DOI: https://doi.org/10.3389/fneur.2021.743169
Yang YH, Liu YQ, Zhang L, et al. Genetic polymorphisms of the TNF-α-308G/A are associated with metabolic syndrome in asthmatic patients from Hebei province, China. Int J Clin Exp Pathol 2015;8:13739-46.
Bosia M, Agostoni G, Repaci F, et al. Cognition in Schizophrenia: modeling the interplay between interleukin-1β C-511T polymorphism, metabolic syndrome, and sex. Neuropsychobiology 2021;80:321-32.
DOI: https://doi.org/10.1159/000512082
Aftabi Y, Gilani N, Ansarin A, et al. Female-biased association of NOS2-c.1823C>T (rs2297518) with co-susceptibility to metabolic syndrome and asthma. Can J Physiol Pharmacol 2023;101:200-13.
DOI: https://doi.org/10.1139/cjpp-2022-0334
Zhu W, Heil D. Associations of vitamin D status with markers of metabolic health: A community-based study in Shanghai, China. Diabetes Metab Syndr 2018;12:727-32.
DOI: https://doi.org/10.1016/j.dsx.2018.04.010
Lu L, Yu Z, Pan A, et al. Plasma 25-hydroxyvitamin D concentration and metabolic syndrome among middle-aged and elderly Chinese individuals. Diabetes Care 2009;32:1278-83.
DOI: https://doi.org/10.2337/dc09-0209
Ghosh J, Chaudhuri D, Saha I, Chaudhuri AN. Prevalence of metabolic syndrome, vitamin D level, and their association among elderly women in a rural community of west Bengal, India. Med J Dr DY Patil University 2020;13:315-20.
DOI: https://doi.org/10.4103/mjdrdypu.mjdrdypu_229_19
Mansouri M, Abasi R, Nasiri M, et al. Association of vitamin D status with metabolic syndrome and its components: A cross-sectional study in a population of high educated Iranian adults. Diabetes Metab Syndr 2018;12:393-8.
DOI: https://doi.org/10.1016/j.dsx.2018.01.007
Majumdar V, Nagaraja D, Christopher R. Vitamin D status and metabolic syndrome in Asian Indians. Int J Obesity 2011;35:1131-4.
DOI: https://doi.org/10.1038/ijo.2010.232
Mahmood SF, Idiculla J, Joshi R, et al. Vitamin D Supplementation in adults with vitamin D deficiency and its effect on metabolic syndrome - a randomized controlled study. Int J Vitam Nutr Res 2016;86:121-6.
DOI: https://doi.org/10.1024/0300-9831/a000426
Jeenduang N, Plyduang T, Horpet D. Association of 25-hydroxyvitamin D levels and metabolic syndrome in Thai postmenopausal women. Diabetes Metab Syndr 2020;14:1580-90.
DOI: https://doi.org/10.1016/j.dsx.2020.08.018
Ghaderian B, Shirinpour Z, Aleali AM, et al. Vitamin D level in non-diabetic adult people with metabolic syndrome. Diabetes Metab Syndr 2019;13;236-8.
DOI: https://doi.org/10.1016/j.dsx.2018.08.003
Farag H, Hosseinzadeh-Attar M, Muhammad B, et al. Effects of vitamin D supplementation along with endurance physical activity on lipid profile in metabolic syndrome patients: a randomized controlled trial. Diabetes Metab Syndr 2019;13:1093-8.
DOI: https://doi.org/10.1016/j.dsx.2019.01.029
Salekzamani S, Mehralizadeh H, Ghezel A, et al. Effect of high-dose vitamin D supplementation on cardiometabolic risk factors in subjects with metabolic syndrome: a randomized controlled double-blind clinical trial. J Endocrinol Invest 2016;39:1303-13.
DOI: https://doi.org/10.1007/s40618-016-0507-8
Wu Y, Li S, Wang W, Zhang D. Associations of dietary vitamin B1, vitamin B2, niacin, vitamin B6, vitamin B12 and folate equivalent intakes with metabolic syndrome. Int J Food Sci Nutr 2020;71:738-49.
DOI: https://doi.org/10.1080/09637486.2020.1719390
Hoseinzadeh-Chahkandak F, Zeinali T, Salmani F, et al. Prevalence of vitamin D deficiency and its association with metabolic syndrome among the elderly population of Birjand, Iran. J Diabetes Metab Disord 2022;21:475-81.
DOI: https://doi.org/10.1007/s40200-022-00998-1
Lim S, Ahn SY, Song IC, et al. Chronic exposure to the herbicide, atrazine, causes mitochondrial dysfunction and insulin resistance. PLoS One 2009;4:e5186.
DOI: https://doi.org/10.1371/journal.pone.0005186
Montgomery MK, Turner N. Mitochondrial dysfunction and insulin resistance: an update. Endocr Connect 2014;4:R1-15.
DOI: https://doi.org/10.1530/EC-14-0092
Yuan H, Yu C, Li X, et al. Serum uric acid levels and risk of metabolic syndrome: a dose-response meta-analysis of prospective studies. J Clin Endocrinol Metab 2015;100:4198-207.
DOI: https://doi.org/10.1210/jc.2015-2527
Yadav D, Lee ES, Kim HM, et al. Prospective study of serum uric acid levels and incident metabolic syndrome in a Korean rural cohort. Atherosclerosis 2015;241;271-7.
DOI: https://doi.org/10.1016/j.atherosclerosis.2015.04.797
Choi HK, Ford ES. Prevalence of the metabolic syndrome in individuals with hyperuricemia. Am J Med 2007;120:442-7.
DOI: https://doi.org/10.1016/j.amjmed.2006.06.040
Jeong J, Suh YJ. Association between serum uric acid and metabolic syndrome in Koreans. J Korean Med Sci 2019;34:e307.
DOI: https://doi.org/10.3346/jkms.2019.34.e307
Ryoo JH, Kim MG, Lee DW, Shin JY. The relationship between serum ferritin and metabolic syndrome in healthy Korean men. Diabetes/Metab Res Rev 2011;27:597-603.
DOI: https://doi.org/10.1002/dmrr.1211
Cho MR, Park JK, Choi WJ, et al. Serum ferritin level is positively associated with insulin resistance and metabolic syndrome in postmenopausal women: a nationwide population-based study. Maturitas 2017;103:3-7.
DOI: https://doi.org/10.1016/j.maturitas.2017.06.004
Fröhlich M, Imhof A, Berg G, et al.Association between C-reactive protein and features of the metabolic syndrome: a population-based study. Diabetes Care 2000;23:1835-9.
DOI: https://doi.org/10.2337/diacare.23.12.1835
Jeong H, Baek SY, Kim SW, et al. C reactive protein level as a marker for dyslipidaemia, diabetes and metabolic syndrome: results from the Korea National Health and Nutrition Examination Survey. BMJ Open 2019;9:e029861.
DOI: https://doi.org/10.1136/bmjopen-2019-029861
Wong ND. Intensified screening and treatment of the metabolic syndrome for cardiovascular risk reduction. Prev Cardiol 2005;8:47-54.
DOI: https://doi.org/10.1111/j.1520-037X.2005.4073.x
Deen D. Metabolic syndrome: time for action. Am Fam Physician 2004;69:2875-82.
National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report. Circulation 2002;106:3143-421.
DOI: https://doi.org/10.1161/circ.106.25.3143
National High Blood Pressure Education Program. The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. Bethesda (MD), USA: National Heart, Lung, and Blood Institute; 2004.
Howard BV, Best LG, Galloway JM, et al.Coronary heart disease risk equivalence in diabetes depends on concomitant risk factors. Diabetes Care 2006;29:391-7.
DOI: https://doi.org/10.2337/diacare.29.02.06.dc05-1299
Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults--The Evidence Report. National Institutes of Health. Obes Res 1998;6:51S-209S.
Ferrannini E, Natali A. Essential hypertension, metabolic disorders, and insulin resistance. Am Heart J 1991;121:1274-82.
DOI: https://doi.org/10.1016/0002-8703(91)90433-I
Malhotra A, Kang BP, Cheung S, et al. Angiotensin II promotes glucose-induced activation of cardiac protein kinase C isozymes and phosphorylation of troponin I. Diabetes 2001;50:1918-26.
DOI: https://doi.org/10.2337/diabetes.50.8.1918
Duvnjak L. Hypertension and the metabolic syndrome. EJIFCC 2007;18:55-60.
Lien LF, Guyton JR. Metabolic syndrome. Dermatol Ther 2008;21:362-75.
DOI: https://doi.org/10.1111/j.1529-8019.2008.00218.x
Lien LF, Angelyn Bethel M, Feinglos MN. In-hospital management of type 2 diabetes mellitus. Med Clin North Am 2004;88:1085-105.
DOI: https://doi.org/10.1016/j.mcna.2004.04.002
Feinglos MN, Bethel MA. Treatment of type 2 diabetes mellitus. Med Clin North Am 1998;82:757-90.
DOI: https://doi.org/10.1016/S0025-7125(05)70023-7
How to Cite
Rao, D. S., Kumar, A., Agarwal, S., Elshaikh, R. H., Choudhary, A., Choudhary, R. K., Babker, A. M. A., Rathore, R., Nurmakhanova, Z., Nurgaliyeva, Z., Musayev, A., & Sah, A. K. (2025). The role of genetic variations in metabolic syndrome: insights into etiology, diagnosis, and management. Italian Journal of Medicine, 19(1). https://doi.org/10.4081/itjm.2025.1908
Copyright (c) 2025 the Author(s)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.